🇺🇸 Cefepime Injection in United States
31 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 31
Most-reported reactions
- Death — 17 reports (54.84%)
- Pulmonary Haemorrhage — 3 reports (9.68%)
- Renal Failure Acute — 3 reports (9.68%)
- Respiratory Failure — 2 reports (6.45%)
- Acute Febrile Neutrophilic Dermatosis — 1 report (3.23%)
- Acute Respiratory Distress Syndrome — 1 report (3.23%)
- Alopecia — 1 report (3.23%)
- Cardiac Failure Acute — 1 report (3.23%)
- Chronic Graft Versus Host Disease — 1 report (3.23%)
- Confusional State — 1 report (3.23%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Cefepime Injection approved in United States?
Cefepime Injection does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Cefepime Injection in United States?
Murdoch Childrens Research Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.